Authors


Samantha J. Peterson

Latest:

Neurological Disorders: Language & Behavior Issues

Studies discussed include neuropsychiatric symptoms leading to mild cognitive impairment and gesture comprehension and language in children with autism.


Samuel Pleasure, MD, PhD

Latest:

Narcolepsy and the Flu

Observations over the last few years have indicated that an inciting event of narcolepsy may be infection with influenza or vaccination with particular influenza vaccines.


Sergio Fantini, PhD

Latest:

A New Tool to Assess Brain Vascular Health

Noninvasive measurements of cerebral hemodynamics and oxygenation can have a significant impact on the assessment of cerebrovascular conditions and can monitor the effects of clinical procedures on brain circulation.


Sreeram Ramagopalan, PhD

Latest:

3 New Findings on Epilepsy

ADHD lowers the quality of life in adults with epilepsy; epilepsy is associated with social deprivation and increased risk of venous thromboembolism: details of these recent findings in this slide show.


Steven A. King, MD, MS

Latest:

Headache: A Pop Quiz

Test your headache IQ here.


Susan Kweskin

Latest:

CGRPs: New Help in Migraine Prophylaxis?

A new class of injectable monoclonal antibodies directed against calcitonin gene related peptide (CGRP) or its receptor may offer hope to migraineurs who have not found effective prophylactic therapy.


Taya Varteresian DO, MS

Latest:

9 Natural Supplements for Cognitive Impairment

Which vitamins and supplements have shown promise in treating dementia and preventing cognitive decline?


Theodore Henderson, MD, PhD

Latest:

Idiopathic Parkinson: Diagnosis of the Deceptive

The emergence of Ioflupane I 123 Injection (DaTSCAN) provides clinicians with helpful information to differentiate idiopathic Parkinson disease from other diseases.


Thomas P. Bravo, MD

Latest:

PACAP: Lessons From A Potent Migraine Inducer?

PACAP38 is a potent aggravator of migraine, a new study shows. This provides several new potential therapeutic targets -- most prominently a specific PACAP receptor PAC1.


Todd J. Schwedt, MD

Latest:

Poor Acute Treatment May Lead to Chronic Migraine

Efficacy of acute medication matters beyond just treating a single migraine. It may increase the risk of worsened disease.


Veronica Hackenthal, MD

Latest:

New Type of Chronic Daily Headache in Older Women?

This case series appears to identify a new subtype of chronic daily headache in overweight/obese women in their fifties and sixties.


Veronica Hackethal MD

Latest:

Probing Headaches: A Diagnostic Challenge Quiz

What differentiates migraine from underlying intracranial pathology that may require neuroimaging, like tumors, abscesses, aneurysms, or hemorrhages? Test your skills with this 5-question quiz.


Veronica Hackethal, MD

Latest:

Chronic Migraine Out of Control Despite Multiple Drug Trials

Your patient asks if a ketogenic diet can reduce her migraines. What will you tell her?


Yuebing Li, MD

Latest:

Finding Consensus: Treating Myasthenia Gravis

The author discusses MG disease classifications as well as treatment goals and treatment adherence.


Dilan Athauda, MBBS, MRCP, BSc

Latest:

Exenatide for Parkinson Symptoms: Early Results Are Positive

Exenatide, a GLP-1 agonist, has been shown to protect neurons. The authors of two small studies of this agent's effects on motor function in Parkinson disease discuss the evidence here.


Pradeep N. Modur, MD, MS

Latest:

Leveraging Technology to Improve Epilepsy Treatment: Responsive Neurostimulation

An update on responsive neurostimulation, the only implantable, closed-loop device approved for treating seizures.


Thomas Foltynie, PhD, MD

Latest:

Exenatide for Parkinson Symptoms: Early Results Are Positive

Exenatide, a GLP-1 agonist, has been shown to protect neurons. The authors of two small studies of this agent's effects on motor function in Parkinson disease discuss the evidence here.


Amy Kao, MD

Latest:

Dietary Therapy to Improve Epilepsy Outcomes: Case Vignettes

The authors present illustrative fictional accounts of patients with medical problems with co-occurring epilepsy.


Brittany Cines, RD, LD, CNSC, CSP

Latest:

Dietary Therapy to Improve Epilepsy Outcomes: Case Vignettes

The authors present illustrative fictional accounts of patients with medical problems with co-occurring epilepsy.


Amit Ban

Latest:

Case Study: Siblings With Hypotonia in All Limbs

Two young siblings presented to the pediatric department with mental retardation, developmental delay, ataxia, and nystagmus since birth. What's your diagnosis after reviewing the case?


Shawn Marshall, MD, MSc

Latest:

Eight Key Features of Post-Concussion Care

It is often unclear which treatments are most appropriate for the constellation of concussion symptoms. Thus, evidence-based education as well as treatment and management options to facilitate recovery are required.


Heather Zwickey, PhD

Latest:

6 Essential Nutrition Recommendations for Parkinson Disease

This article provides some straightforward nutritional recommendations that neurologists can share with their patients.


Kathleen M. Shannon, MD, FAAN, FANA

Latest:

The Gut Has It: Microbes and Parkinson

While it is premature to conclude that changes in intestinal microbes influence the genesis or progression of PD, preliminary evidence indicates that they may be associated with inflammation in the intestinal wall.


David Y. Hwang, MD

Latest:

Top Issues in Emergency Neurology Today

Neurology on the front lines engages patients and their families in a shared decision-making process regarding goals of care.


Tracy T. Batchelor, MD

Latest:

Neurocognitive Outcomes in Primary CNS Lymphoma: Clinical Implications

Primary central nervous system lymphoma (PCNSL) is a rare but aggressive malignancy that accounts for approximately 3% of all primary CNS cancer. New studies have changed the landscape of PCNSL treatment paradigms and expectations for outcome.


Michael W. Parsons, PhD

Latest:

Neurocognitive Outcomes in Primary CNS Lymphoma: Clinical Implications

Primary central nervous system lymphoma (PCNSL) is a rare but aggressive malignancy that accounts for approximately 3% of all primary CNS cancer. New studies have changed the landscape of PCNSL treatment paradigms and expectations for outcome.


Kasra Maasumi, MD, MS

Latest:

Treating Menstrual Migraines

Given the severity and treatment resistance of menstrual migraine, clinicians should watch for the signs and symptoms discussed in this case.


Patrick W. Hullett, MD, PhD

Latest:

Treating Menstrual Migraines

Given the severity and treatment resistance of menstrual migraine, clinicians should watch for the signs and symptoms discussed in this case.


Murtaza Khan, MD

Latest:

Differential Diagnosis of Meningitis and Encephalitis

The authors distinguish between the clinical entities of meningitis, encephalitis, and encephalopathy.


Amanda L Piquet, MD

Latest:

Differential Diagnosis of Meningitis and Encephalitis

The authors distinguish between the clinical entities of meningitis, encephalitis, and encephalopathy.

© 2024 MJH Life Sciences

All rights reserved.